[ Price : $8.95]
Eli Lilly reports Phase 3 study results showing its oral GLP-1 receptor agonist Foundayo (orforglipron) outperformed Novo Nordisk'...[ Price : $8.95]
Delegates at the American Medical Association's annual meeting vote to support stronger FDA oversight of synthetic peptide product...[ Price : $8.95]
FDA places a clinical hold on Quantum BioPharmas IND for its multiple sclerosis drug candidate Lucid-21-302.[ Price : $8.95]
Eight Mintz attorneys analyze the recent Supreme Court decision giving generic drug manufacturers a victory in an induced infringe...[ Price : $8.95]
Former FDA enforcement official suggests new strategies for industry to prepare for agency inspections that rely on artificial int...[ Price : $8.95]
FDA officials are seeking to bolster confidence in generic medicines, highlighting the agency's oversight of drug manufacturing, i...[ Price : $8.95]
FDA launches a new effort to aggregate clinical trial data on kidney safety biomarkers, seeking pharmaceutical industry participat...[ Price : $8.95]
FDA issues an early alert warning healthcare providers about a potentially high-risk defect affecting certain infant resuscitation...